Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	6.46e-05	2	161	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	6.46e-05	2	161	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	6.46e-05	2	161	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	6.46e-05	2	161	2	GO:0004354
GeneOntologyMolecularFunction	NADH oxidase H202-forming activity	DUOX2 DUOX1	6.46e-05	2	161	2	GO:0106293
GeneOntologyMolecularFunction	alpha-1A adrenergic receptor binding	ARRB1 ARRB2	6.46e-05	2	161	2	GO:0031691
GeneOntologyMolecularFunction	actin filament binding	MYO1D ANXA8L1 ANXA8 SHROOM2 FMNL3 CYFIP1 SVIL CTNNA2 AJUBA	9.68e-05	227	161	9	GO:0051015
GeneOntologyMolecularFunction	store-operated calcium channel activity	TRPC7 TRPC3 TRPC6	1.07e-04	12	161	3	GO:0015279
GeneOntologyMolecularFunction	inositol 1,4,5 trisphosphate binding	TRPC7 TRPC3 TRPC6	1.75e-04	14	161	3	GO:0070679
GeneOntologyMolecularFunction	follicle-stimulating hormone receptor binding	ARRB1 ARRB2	1.93e-04	3	161	2	GO:0031762
GeneOntologyMolecularFunction	alpha-1B adrenergic receptor binding	ARRB1 ARRB2	1.93e-04	3	161	2	GO:0031692
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	ATR PRKDC	1.93e-04	3	161	2	GO:0035979
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH10 DNAH6 DYNC1H1	3.84e-04	18	161	3	GO:0008569
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors	DDO GLUD1 GLUD2	5.30e-04	20	161	3	GO:0016638
GeneOntologyMolecularFunction	NAD+ binding	PARP14 GLUD1 GLUD2	5.30e-04	20	161	3	GO:0070403
GeneOntologyMolecularFunction	histone H2AX kinase activity	ATR PRKDC	6.36e-04	5	161	2	GO:0141003
GeneOntologyMolecularFunction	NADPH oxidase H202-forming activity	DUOX2 DUOX1	6.36e-04	5	161	2	GO:0106294
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	SETMAR DDX49 POLR1A DHX37 RPP40 POLE CHD9 MLH3 KARS1 FEN1 PAN2 QARS1 TARS1 DNMT3B	7.51e-04	645	161	14	GO:0140640
GeneOntologyMolecularFunction	calcium ion sensor activity	EFHD1 MICU2	1.32e-03	7	161	2	GO:0061891
GeneOntologyMolecularFunction	centromeric DNA binding	MLH3 ZW10	1.32e-03	7	161	2	GO:0019237
GeneOntologyMolecularFunction	L-leucine binding	GLUD1 GLUD2	1.32e-03	7	161	2	GO:0070728
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH10 DNAH6 DYNC1H1	1.45e-03	28	161	3	GO:0051959
GeneOntologyMolecularFunction	metal ion sensor activity	EFHD1 MICU2	1.75e-03	8	161	2	GO:0140784
Domain	TRP_2	TRPC7 TRPC3 TRPC6	1.23e-05	6	161	3	PF08344
Domain	TRP_dom	TRPC7 TRPC3 TRPC6	1.23e-05	6	161	3	IPR013555
Domain	TRPC_channel	TRPC7 TRPC3 TRPC6	2.15e-05	7	161	3	IPR002153
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	7.39e-05	2	161	2	PF02812
Domain	Cytoplasmic_FMR1-int	CYFIP2 CYFIP1	7.39e-05	2	161	2	IPR008081
Domain	AnnexinVIII	ANXA8L1 ANXA8	7.39e-05	2	161	2	IPR009115
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	7.39e-05	2	161	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	7.39e-05	2	161	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	7.39e-05	2	161	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	7.39e-05	2	161	2	PF00208
Domain	DUOX1	DUOX2 DUOX1	7.39e-05	2	161	2	IPR029595
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	7.39e-05	2	161	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	7.39e-05	2	161	2	PS00074
Domain	ELFV_dehydrog	GLUD1 GLUD2	7.39e-05	2	161	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	7.39e-05	2	161	2	IPR033524
Domain	FragX_IP	CYFIP2 CYFIP1	7.39e-05	2	161	2	PF05994
Domain	TRP_channel	TRPC7 TRPC3 TRPC6	9.86e-05	11	161	3	IPR004729
Domain	ARM-type_fold	DOCK1 ATR FRYL CWC22 WDFY4 LYST FMNL3 PI4KA EIF4G1 PRKDC UNC79	1.77e-04	339	161	11	IPR016024
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	IPR013602
Domain	DHC_N2	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	IPR011704
Domain	MT	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	PF12777
Domain	AAA_8	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	PF12780
Domain	AAA_5	DNAH10 DNAH6 DYNC1H1	2.13e-04	14	161	3	PF07728
Domain	REKLES	ARID3A ARID3C	2.20e-04	3	161	2	PS51486
Domain	REKLES_domain	ARID3A ARID3C	2.20e-04	3	161	2	IPR023334
Domain	DHC_fam	DNAH10 DNAH6 DYNC1H1	2.65e-04	15	161	3	IPR026983
Domain	Dynein_heavy	DNAH10 DNAH6 DYNC1H1	2.65e-04	15	161	3	PF03028
Domain	PI3/4_kinase_CS	ATR PI4KA PRKDC	2.65e-04	15	161	3	IPR018936
Domain	Dynein_heavy_dom	DNAH10 DNAH6 DYNC1H1	2.65e-04	15	161	3	IPR004273
Domain	-	ATR PI4KA PRKDC	3.24e-04	16	161	3	1.10.1070.11
Domain	PI3Kc	ATR PI4KA PRKDC	3.24e-04	16	161	3	SM00146
Domain	Arrestin_N	ARRB1 ARRB2	4.38e-04	4	161	2	IPR014753
Domain	DUF1394	CYFIP2 CYFIP1	4.38e-04	4	161	2	IPR009828
Domain	Arrestin_CS	ARRB1 ARRB2	4.38e-04	4	161	2	IPR017864
Domain	ARRESTINS	ARRB1 ARRB2	4.38e-04	4	161	2	PS00295
Domain	DUF1394	CYFIP2 CYFIP1	4.38e-04	4	161	2	PF07159
Domain	Arrestin	ARRB1 ARRB2	4.38e-04	4	161	2	IPR000698
Domain	-	ARRB1 ARRB2	4.38e-04	4	161	2	2.60.40.840
Domain	PI3_PI4_kinase	ATR PI4KA PRKDC	4.66e-04	18	161	3	PF00454
Domain	PI3_4_KINASE_1	ATR PI4KA PRKDC	4.66e-04	18	161	3	PS00915
Domain	PI3_4_KINASE_2	ATR PI4KA PRKDC	4.66e-04	18	161	3	PS00916
Domain	PI3/4_kinase_cat_dom	ATR PI4KA PRKDC	4.66e-04	18	161	3	IPR000403
Domain	PI3_4_KINASE_3	ATR PI4KA PRKDC	4.66e-04	18	161	3	PS50290
Domain	FATC	ATR PRKDC	7.26e-04	5	161	2	PF02260
Domain	TPR-like_helical_dom	RGPD2 POLR1A ATR GPS1 TRAPPC12 CTR9 C8orf76 PRKDC	9.52e-04	233	161	8	IPR011990
Domain	MA3	CWC22 EIF4G1	1.08e-03	6	161	2	SM00544
Domain	MA3	CWC22 EIF4G1	1.08e-03	6	161	2	PF02847
Domain	Initiation_fac_eIF4g_MI	CWC22 EIF4G1	1.08e-03	6	161	2	IPR003891
Domain	FAT	ATR PRKDC	1.08e-03	6	161	2	PS51189
Domain	FATC	ATR PRKDC	1.08e-03	6	161	2	PS51190
Domain	FAT	ATR PRKDC	1.08e-03	6	161	2	PF02259
Domain	MI	CWC22 EIF4G1	1.08e-03	6	161	2	PS51366
Domain	PIK-rel_kinase_FAT	ATR PRKDC	1.08e-03	6	161	2	IPR003151
Domain	FATC_dom	ATR PRKDC	1.08e-03	6	161	2	IPR003152
Domain	PIK_FAT	ATR PRKDC	1.08e-03	6	161	2	IPR014009
Domain	FATC	ATR PRKDC	1.08e-03	6	161	2	SM01343
Domain	-	ARRB1 ARRB2	1.51e-03	7	161	2	2.60.40.640
Domain	NAD_binding_6	DUOX2 DUOX1	1.51e-03	7	161	2	PF08030
Domain	FAD_binding_8	DUOX2 DUOX1	1.51e-03	7	161	2	PF08022
Domain	FAD-bd_8	DUOX2 DUOX1	1.51e-03	7	161	2	IPR013112
Domain	Fe_red_NAD-bd_6	DUOX2 DUOX1	1.51e-03	7	161	2	IPR013121
Domain	Arrestin_C	ARRB1 ARRB2	2.00e-03	8	161	2	IPR014752
Domain	DHC_N1	DNAH10 DYNC1H1	2.00e-03	8	161	2	PF08385
Domain	PH-BEACH_dom	WDFY4 LYST	2.00e-03	8	161	2	IPR023362
Domain	Calx_beta	FREM3 FREM2	2.00e-03	8	161	2	SM00237
Domain	-	WDFY4 LYST	2.00e-03	8	161	2	2.30.29.40
Domain	PH_BEACH	WDFY4 LYST	2.00e-03	8	161	2	PS51783
Domain	Dynein_heavy_dom-1	DNAH10 DYNC1H1	2.00e-03	8	161	2	IPR013594
Domain	EFh	DUOX2 CAPN8 DUOX1 NECAB1 EFHD1 MICU2	2.50e-03	158	161	6	SM00054
Domain	Calx_beta	FREM3 FREM2	2.55e-03	9	161	2	IPR003644
Domain	BEACH	WDFY4 LYST	2.55e-03	9	161	2	PS50197
Domain	Beach	WDFY4 LYST	2.55e-03	9	161	2	PF02138
Domain	-	WDFY4 LYST	2.55e-03	9	161	2	1.10.1540.10
Domain	Beach	WDFY4 LYST	2.55e-03	9	161	2	SM01026
Domain	BEACH_dom	WDFY4 LYST	2.55e-03	9	161	2	IPR000409
Domain	Calx-beta	FREM3 FREM2	2.55e-03	9	161	2	PF03160
Domain	Ion_trans_dom	TRPC7 TRPC3 TRPC6 HCN3 RYR1	3.09e-03	114	161	5	IPR005821
Domain	Ion_trans	TRPC7 TRPC3 TRPC6 HCN3 RYR1	3.09e-03	114	161	5	PF00520
Domain	Arrestin-like_N	ARRB1 ARRB2	3.18e-03	10	161	2	IPR011021
Domain	Arrestin_C-like	ARRB1 ARRB2	3.18e-03	10	161	2	IPR011022
Domain	MIF4G	CWC22 EIF4G1	3.18e-03	10	161	2	SM00543
Domain	An_peroxidase	DUOX2 DUOX1	3.18e-03	10	161	2	PF03098
Domain	MIF4G	CWC22 EIF4G1	3.18e-03	10	161	2	PF02854
Domain	Haem_peroxidase_animal	DUOX2 DUOX1	3.18e-03	10	161	2	IPR019791
Domain	Arrestin_C	ARRB1 ARRB2	3.18e-03	10	161	2	SM01017
Domain	MIF4G-like_typ-3	CWC22 EIF4G1	3.18e-03	10	161	2	IPR003890
Domain	Haem_peroxidase	DUOX2 DUOX1	3.18e-03	10	161	2	IPR010255
Domain	Arrestin_C	ARRB1 ARRB2	3.18e-03	10	161	2	PF02752
Domain	Arrestin_N	ARRB1 ARRB2	3.18e-03	10	161	2	PF00339
Domain	PEROXIDASE_3	DUOX2 DUOX1	3.18e-03	10	161	2	PS50292
Domain	-	DUOX2 DUOX1	3.18e-03	10	161	2	1.10.640.10
Domain	-	LAMA2 CNTNAP2 HERC2 DCBLD2	3.65e-03	73	161	4	2.60.120.260
Domain	EF_hand_dom	DUOX2 RYR1 CAPN8 DUOX1 NECAB1 EFHD1 MICU2	4.04e-03	232	161	7	IPR002048
Domain	calpain_III	CAPN6 CAPN8	4.61e-03	12	161	2	SM00720
Domain	Ferric_reduct	DUOX2 DUOX1	4.61e-03	12	161	2	PF01794
Domain	C2_III	CAPN6 CAPN8	4.61e-03	12	161	2	IPR033883
Domain	Calpain_III	CAPN6 CAPN8	4.61e-03	12	161	2	IPR022683
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ATP6V1A POLR1A ATR MYO1D DNAH10 RPS2 DHX37 POLE DUOX2 GPATCH4 KRR1 CWC22 CYFIP2 SART1 UBE2O KARS1 CYFIP1 GTF3C1 CTR9 PI4KA GLUD1 EIF4G1 FEN1 PRKDC PEAK1 SNRPA ATP1B3 QARS1 TALDO1 EIF2AK2 TARS1 DYNC1H1 ADGRA3	2.35e-14	1425	163	33	30948266
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DDX49 POLR1A UBE4B RPS2 DHX37 POLE DLGAP5 GPATCH4 KRR1 RRM2 BLVRA SART1 KARS1 CYFIP1 PTPN14 ARRB2 GTF3C1 CTR9 PI4KA EIF4G1 FEN1 PYGL PRKDC HERC2 SNRPA QARS1 MGA EIF2AK2 TARS1 DYNC1H1	1.27e-12	1353	163	30	29467282
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	KRT78 MYO1D DHX37 KRT82 POLE GPS1 ELOVL1 FRYL OAZ2 MET ARRB1 ARRB2 EFHD1 PPP4R2 UBAC1 EIF4G1 FIBP IRS2 HERC2 ZW10 NME2 SNRPA ATP1B3 EIF2AK2 UNC79 TARS1 DYNC1H1	6.44e-11	1284	163	27	17353931
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HEXA MPP3 TRAF7 ARID3A SH3RF1 UBE4B POLE FRYL BCR LYST RYR1 FZD7 UNC119 NCOR1 SLC7A1 TRAPPC12 PI4KA EIF4G1 IRS2 PRKDC HERC2 MYRF DYNC1H1	2.36e-09	1105	163	23	35748872
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	ATP6V1A POLR1A UBE4B POLE GPS1 SLC7A1 UBE2O KARS1 SLC12A2 PI4KA EIF4G1 FEN1 TRAPPC3 PRKDC ZW10 ATP1B3 QARS1 SNX9 RAB6A TARS1 DYNC1H1	3.80e-09	942	163	21	31073040
Pubmed	Global landscape of HIV-human protein complexes.	DDX49 POLE GPS1 GPATCH4 RRM2 NCOR1 UBE2O KARS1 ARRB2 PRKDC HERC2 QARS1 EIF2AK2 TARS1 DYNC1H1	4.87e-09	457	163	15	22190034
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	ATP6V1A RPS2 TCP11L1 CYFIP2 UBE2O KARS1 CYFIP1 GTF3C1 SVIL GLUD1 EIF4G1 FEN1 PYGL TRAPPC3 PRKDC ZW10 NME2 QARS1 SNX9 TALDO1 EIF2AK2 TARS1 DYNC1H1	4.91e-09	1149	163	23	35446349
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	ATP6V1A RPS2 RPP40 GPATCH4 KRR1 PPWD1 SART1 UBE2O KARS1 CYFIP1 ARRB1 ARRB2 TRIR CTR9 GLUD1 EIF4G1 FEN1 IRS2 TRAPPC3 PRKDC SNRPA QARS1 EIF2AK2 TARS1 DYNC1H1	1.19e-08	1415	163	25	28515276
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ATP6V1A POLR1A ATR POLE CHD9 PPWD1 BLVRA SART1 NCOR1 KARS1 TRIR GTF3C1 CTR9 PPP4R2 EIF4G1 PYGL PRKDC SNRPA TALDO1 EIF2AK2 TARS1	1.36e-08	1014	163	21	32416067
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	POLR1A MYO1D RPS2 DHX37 POLE FRYL KRR1 SART1 UBE2O KARS1 GTF3C1 EIF4G1 PYGL PRKDC HERC2 SNX9 DYNC1H1	1.38e-08	653	163	17	22586326
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ATP6V1A KRT78 POLR1A MYO1D RPS2 KRT82 SART1 SLC12A2 GTF3C1 PI4KA SVIL GLUD1 EIF4G1 PRKDC HERC2 SNRPA QARS1 MGA SNX9 TARS1 DYNC1H1	1.61e-08	1024	163	21	24711643
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	KRT78 MYO1D RPS2 DHX37 KRR1 CWC22 SART1 KARS1 CYFIP1 PTPN14 GTF3C1 SVIL GLUD1 EIF4G1 FEN1 PRKDC MICU2 SNRPA AJUBA QARS1 EIF2AK2 TARS1 DYNC1H1	2.58e-08	1257	163	23	36526897
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD2 HCN3 DLGAP5 JAKMIP3 BCR CYFIP2 SART1 NCOR1 UBE2O CYFIP1 PI4KA SVIL EIF4G1 TRAPPC3 CTNNA2 HERC2 ARHGEF26 MGA UNC79 DYNC1H1	2.96e-08	963	163	20	28671696
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DOCK1 KRT78 ATR FRYL PARP14 PI4KA EIF4G1 CNTNAP2 PRKDC HERC2	4.45e-08	202	163	10	33005030
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	DDX49 ARID3A CHD9 PPWD1 SART1 NCOR1 KARS1 TRIR GTF3C1 CTR9 PPP4R2 FEN1 PYGL PRKDC ZW10 NME2 SNRPA SNX9 TALDO1 TARS1 DYNC1H1	5.68e-08	1103	163	21	34189442
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD2 FAM114A1 GGNBP2 MYO1D GPS1 ASH1L DUOX2 VPS36 LYST CYFIP2 SART1 NCOR1 ARRB1 GTF3C1 CTR9 GLUD1 GLUD2 EIF4G1 PRKDC NME2 SNX9 DNAH6 AMIGO2 DNMT3B	7.34e-08	1442	163	24	35575683
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	HEXA ATP6V1A FAM114A1 UBE4B RPS2 RPP40 GPS1 FRYL VPS36 UBE2O KARS1 CYFIP1 CTR9 PPP4R2 EIF4G1 FEN1 PYGL PRKDC ZW10 SNRPA QARS1 TALDO1 TARS1 DYNC1H1	8.67e-08	1455	163	24	22863883
Pubmed	Major contribution of the 3/6/7 class of TRPC channels to myocardial ischemia/reperfusion and cellular hypoxia/reoxygenation injuries.	TRPC7 TRPC3 TRPC6	1.01e-07	3	163	3	28526717
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	RGPD2 ATP6V1A POLR1A RPS2 DHX37 POLE RRM2 NCOR1 KARS1 CYFIP1 GTF3C1 CTR9 GLUD1 GLUD2 EIF4G1 PYGL PRKDC NME2 SNRPA QARS1 TARS1 DYNC1H1	1.15e-07	1257	163	22	37317656
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CHD9 FRYL CYFIP2 NCOR1 COG6 CTR9 TBC1D14	1.86e-07	87	163	7	12465718
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	MYO1D RPS2 POLE GPATCH4 SART1 KARS1 GTF3C1 GLUD1 EIF4G1 PRKDC SNRPA ATP1B3 QARS1 SNX9 EIF2AK2 DYNC1H1	3.50e-07	725	163	16	27025967
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	ATP6V1A RPS2 GPS1 RRM2 UBE2O KARS1 CYFIP1 CTR9 EIF4G1 PRKDC ZW10 SNRPA QARS1 TARS1 DYNC1H1	3.75e-07	638	163	15	33239621
Pubmed	Melanopsin Phototransduction Is Repurposed by ipRGC Subtypes to Shape the Function of Distinct Visual Circuits.	TRPC7 TRPC3 TRPC6	4.03e-07	4	163	3	30017393
Pubmed	Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling.	TRPC3 ARRB1 ARRB2	4.03e-07	4	163	3	28181498
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ATP6V1A MYO1D RPS2 CHD9 GPATCH4 CYFIP2 SART1 NCOR1 CYFIP1 PTPN14 SVIL GLUD1 EIF4G1 PRKDC NME2 QARS1 MGA TALDO1 EIF2AK2 TARS1 DYNC1H1	4.31e-07	1247	163	21	27684187
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	ATP6V1A RPP40 CWC22 KARS1 CYFIP1 PTPN14 GTF3C1 GLUD1 PRKDC QARS1 TARS1 DYNC1H1	4.51e-07	399	163	12	37536630
Pubmed	Defining the membrane proteome of NK cells.	HEXA CCDC134 ACAP1 RPS2 ELOVL1 KRR1 PARP14 BCR CYFIP2 NCOR1 SLC7A1 GTF3C1 PI4KA EIF4G1 FEN1 PRKDC HERC2 ZW10 EIF2AK2 DYNC1H1	6.41e-07	1168	163	20	19946888
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SETMAR UBE4B ASH1L CHD9 JAKMIP3 SHROOM2 ZNF879 UBE2O ARRB1 NECAB1 CTR9 GLUD1 EIF4G1 FIBP PRKDC HERC2 R3HDM1 QARS1 RAB6A TARS1 DYNC1H1	6.98e-07	1285	163	21	35914814
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TRAF7 CWF19L2 SH3RF1 MYO1D BCR NCOR1 CYFIP1 PTPN14 CTR9 PI4KA PPP4R2 NME2 SNX9 RAB6A	8.05e-07	588	163	14	38580884
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	FLT1 SH3RF1 HCN3 GPS1 ASH1L COL22A1 KRR1 NCOR1 UBE2O TRAPPC12 SVIL FEN1 PYGL SNRPA MGA	9.81e-07	689	163	15	36543142
Pubmed	Intrinsic phototransduction persists in melanopsin-expressing ganglion cells lacking diacylglycerol-sensitive TRPC subunits.	TRPC7 TRPC3 TRPC6	1.00e-06	5	163	3	21261756
Pubmed	TRPC channels are necessary mediators of pathologic cardiac hypertrophy.	TRPC7 TRPC3 TRPC6	1.00e-06	5	163	3	20351294
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP6V1A KRT78 MYO1D RPS2 SHROOM2 BCR CYFIP2 UBE2O KARS1 CYFIP1 PI4KA SVIL GLUD1 GLUD2 EIF4G1 TRAPPC3 CTNNA2 PEAK1 NME2 DNAH6 TARS1 DYNC1H1	1.02e-06	1431	163	22	37142655
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ATP6V1A POLR1A RPS2 DHX37 GPATCH4 KRR1 CWC22 BLVRA NCOR1 KARS1 CTR9 GLUD1 EIF4G1 FEN1 PYGL PRKDC SNRPA QARS1 TALDO1 EIF2AK2 DYNC1H1	1.05e-06	1318	163	21	30463901
Pubmed	Dynamic regulation of sarcoplasmic reticulum Ca(2+) stores by stromal interaction molecule 1 and sarcolipin during muscle differentiation.	TRPC7 TRPC3 TRPC6 RYR1	1.06e-06	17	163	4	22411552
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	RPS2 DLGAP5 SART1 ARRB1 ARRB2 EIF4G1 PYGL PRKDC QARS1 MGA EIF2AK2 TARS1	1.29e-06	441	163	12	31239290
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ATP6V1A RPS2 ASH1L RYR1 CYFIP2 DUOX1 SLC12A2 EIF4G1 PRKDC PEAK1 QARS1 TALDO1 UNC79 RAB6A TARS1 DYNC1H1	1.42e-06	807	163	16	30575818
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RGPD2 DDX49 ATR DHX37 GPATCH4 RRM2 GTF3C1 EIF4G1 FEN1 SNRPA DYNC1H1	1.54e-06	370	163	11	22922362
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	KRT78 POLR1A MYO1D DHX37 GPATCH4 BCR CYFIP2 BLVRA SART1 TRIR EIF4G1 R3HDM1 QARS1 MGA SNX9	1.81e-06	724	163	15	36232890
Pubmed	Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.	LYST CD40LG PRKDC	2.00e-06	6	163	3	10841521
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	ATP6V1A MYO1D BCR FMNL3 SART1 SLC12A2 GTF3C1 PI4KA SVIL HERC2	2.47e-06	313	163	10	38270169
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	RGPD2 TCP11L1 ADA KARS1 GLUD1 GLUD2 EIF4G1 PYGL PRKDC CTNNA2 NME2 QARS1 SNX9 EIF2AK2 TARS1 DYNC1H1	2.53e-06	844	163	16	25963833
Pubmed	MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.	ATP6V1A RPS2 CYFIP2 BLVRA CYFIP1 SLC12A2 PI4KA NME2 ATP1B3 TALDO1 RAB6A TARS1 DYNC1H1	2.93e-06	565	163	13	20458337
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	HEXA ATP6V1A DHX37 COL22A1 BCR SART1 MMP24 KARS1 PI4KA GLUD2 EIF4G1 SNRPA MGA RAB6A DYNC1H1	2.96e-06	754	163	15	35906200
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	HEXA CCDC134 ATP6V1A RPS2 DHX37 DLGAP5 GPATCH4 RRM2 BLVRA SART1 MET NCOR1 CYFIP1 PRKDC CTNNA2 SNRPA QARS1 EIF2AK2 RAB6A DYNC1H1	3.16e-06	1297	163	20	33545068
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KRT78 SH3RF1 FRYL RRM2 BCR LYST UNC119 PTPN14 SLC12A2 CEP95 PI4KA SVIL EIF4G1 IRS2 PEAK1 R3HDM1	3.26e-06	861	163	16	36931259
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	ATP6V1A GPS1 UBE2O KARS1 GTF3C1 EFHD1 PI4KA PYGL PRKDC NME2 ATP1B3 TARS1 DYNC1H1	3.29e-06	571	163	13	37167062
Pubmed	MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC.	TRPC7 TRPC3 TRPC6	3.49e-06	7	163	3	15757897
Pubmed	TRPC absence induces pro-inflammatory macrophages and gut microbe disorder, sensitizing mice to colitis.	TRPC7 TRPC3 TRPC6	3.49e-06	7	163	3	36592529
Pubmed	Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models.	TRPC7 TRPC3 TRPC6	3.49e-06	7	163	3	15336983
Pubmed	RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis.	GLUD1 GLUD2 PYGL	3.49e-06	7	163	3	19498109
Pubmed	RNA-seq analysis reveals TRPC genes to impact an unexpected number of metabolic and regulatory pathways.	TRPC7 TRPC3 TRPC6	3.49e-06	7	163	3	32350291
Pubmed	TRPC absence induces pro-inflammatory macrophage polarization to promote obesity and exacerbate colorectal cancer.	TRPC7 TRPC3 TRPC6	3.49e-06	7	163	3	38835669
Pubmed	Subunit composition, molecular environment, and activation of native TRPC channels encoded by their interactomes.	TRPC7 TRPC3 TRPC6	3.49e-06	7	163	3	36257322
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	RPS2 FRYL SHROOM2 CYFIP2 PTPN14 SVIL IRS2 PRKDC DYNC1H1	3.56e-06	255	163	9	15324660
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	FLT1 POLR1A DHX37 GPS1 CHD9 VPS36 MMP20 SART1 CYFIP1 GTF3C1 IRS2 QARS1	4.39e-06	497	163	12	36774506
Pubmed	Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.	BLVRA GLUD1 EIF4G1 PYGL IRS2 EIF2AK2 DYNC1H1	5.35e-06	143	163	7	30397336
Pubmed	Metabolism regulates the spontaneous firing of substantia nigra pars reticulata neurons via KATP and nonselective cation channels.	TRPC7 TRPC3 TRPC6	5.56e-06	8	163	3	25471572
Pubmed	Association of immunophilins with mammalian TRPC channels.	TRPC7 TRPC3 TRPC6	5.56e-06	8	163	3	15199065
Pubmed	Subunit composition of mammalian transient receptor potential channels in living cells.	TRPC7 TRPC3 TRPC6	5.56e-06	8	163	3	12032305
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	POLR1A UBE4B RPS2 DHX37 POLE GPS1 BLVRA KARS1 CYFIP1 GTF3C1 FEN1 PRKDC EIF2AK2 DYNC1H1	6.44e-06	704	163	14	29955894
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	RPS2 KARS1 PI4KA GLUD1 EIF4G1 FEN1 TRAPPC3 PRKDC ZW10 SNRPA QARS1 TALDO1 TARS1 DYNC1H1	6.76e-06	707	163	14	19738201
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DOCK1 SH3RF1 RPS2 CYFIP1 EIF4G1 IRS2 PRKDC PEAK1 ATP1B3 QARS1 ARHGEF26 SNX9 TARS1 DYNC1H1	6.87e-06	708	163	14	39231216
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	ATP6V1A RPS2 GPATCH4 SART1 NCOR1 CTR9 PRKDC NME2 MGA DYNC1H1	7.86e-06	357	163	10	37059091
Pubmed	Cellular subtype distribution and developmental regulation of TRPC channel members in the mouse dorsal root ganglion.	TRPC7 TRPC3 TRPC6	8.32e-06	9	163	3	17480026
Pubmed	Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase.	ATR PRKDC EIF2AK2	8.32e-06	9	163	3	10747897
Pubmed	Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels.	TRPC7 TRPC3 TRPC6	8.32e-06	9	163	3	11290752
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RGPD2 DDX49 TCP11L1 GPS1 ANXA8L1 ANXA8 GPATCH4 CWC22 SART1 ARRB1 ARRB2 GTF3C1 SVIL EIF4G1 PRKDC HERC2 ZW10 DYNC1H1	8.82e-06	1155	163	18	20360068
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	RPS2 GPS1 PPWD1 CAPN8 SART1 UBE2O PI4KA EIF4G1 FEN1 TALDO1 TARS1 DYNC1H1	9.75e-06	538	163	12	28524877
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	DDX49 RPS2 DHX37 RPP40 GPS1 GPATCH4 SART1 UBE2O GTF3C1 GLUD1 PRKDC MGA	1.15e-05	547	163	12	37267103
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	CWF19L2 DLGAP5 GPATCH4 KRR1 CWC22 CYFIP2 SART1 NCOR1 CYFIP1 TRIR EIF4G1 FEN1 PRKDC NME2 SNRPA MGA	1.17e-05	954	163	16	36373674
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	GGNBP2 POLR1A RPS2 DHX37 RPP40 GPATCH4 KRR1 SART1 NCOR1 CYFIP1 GTF3C1 EIF4G1 FEN1 PRKDC QARS1	1.18e-05	847	163	15	35850772
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	ATP6V1A POLR1A RPS2 CYFIP2 SART1 KARS1 CYFIP1 EIF4G1 FEN1 PRKDC NME2 QARS1 TALDO1 DNAH6 DYNC1H1	1.18e-05	847	163	15	35235311
Pubmed	The leak channel NALCN controls tonic firing and glycolytic sensitivity of substantia nigra pars reticulata neurons.	TRPC7 TRPC3 TRPC6	1.18e-05	10	163	3	27177420
Pubmed	Heterogeneous distribution of TRPC proteins in the embryonic cortex.	TRPC7 TRPC3 TRPC6	1.18e-05	10	163	3	18989690
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CWF19L2 KRT78 DDX49 RPS2 DHX37 CHD9 CWC22 SART1 KARS1 GTF3C1 EIF4G1 FEN1 PAN2 PRKDC SNRPA DYNC1H1 DNMT3B	1.43e-05	1082	163	17	38697112
Pubmed	High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.	MYO1D DHX37 GPS1 GPATCH4 SART1 KARS1 CYFIP1 EIF4G1 SNRPA QARS1 EIF2AK2	1.46e-05	469	163	11	37314180
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	POLR1A RPS2 DHX37 POLE GPATCH4 KRR1 SART1 KARS1 GTF3C1 EIF4G1 PRKDC HERC2 QARS1 EIF2AK2	1.49e-05	759	163	14	35915203
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ARID3A TCP11L1 GPS1 BCR SART1 UNC119 KARS1 CYFIP1 PTPN14 CTR9 PPP4R2 PAN2 PYGL TRAPPC3 ZW10 QARS1 SNX9 RAB6A DYNC1H1	1.51e-05	1321	163	19	27173435
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	ATP6V1A POLR1A PPWD1 CWC22 SART1 ARRB2 CTR9 PI4KA SVIL EIF4G1 PRKDC SNRPA EIF2AK2	1.54e-05	660	163	13	32780723
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	FREM2 CYFIP1 PRKDC DYNC1H1 ADGRA3	1.62e-05	67	163	5	21875946
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	PARP14 MET SLC7A1 PTPN14 SLC12A2 PI4KA PEAK1 ARHGEF26 MYRF DCBLD2 RAB6A AMIGO2	1.70e-05	569	163	12	30639242
Pubmed	Integrated Transcriptome and Network Analysis Reveals Spatiotemporal Dynamics of Calvarial Suturogenesis.	CAPN6 COL22A1 CAPN8 CTNNA2	1.71e-05	33	163	4	32640236
Pubmed	Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.	ATR POLE MLH3 FEN1 PRKDC	1.75e-05	68	163	5	20496165
Pubmed	Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism.	DUOX2 DUOX1	2.18e-05	2	163	2	28633507
Pubmed	Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2.	ARRB1 ARRB2	2.18e-05	2	163	2	18703513
Pubmed	Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.	GLUD1 GLUD2	2.18e-05	2	163	2	34173171
Pubmed	Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.	GLUD1 GLUD2	2.18e-05	2	163	2	28621566
Pubmed	TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.	TRPC3 TRPC6	2.18e-05	2	163	2	22724068
Pubmed	TaqI polymorphisms at the annexin VIII locus (ANX8).	ANXA8L1 ANXA8	2.18e-05	2	163	2	1364010
Pubmed	Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function.	ARRB1 ARRB2	2.18e-05	2	163	2	28973019
Pubmed	An immunocompromised murine model of chronic Bartonella infection.	LYST PRKDC	2.18e-05	2	163	2	20395436
Pubmed	Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo.	ARRB1 ARRB2	2.18e-05	2	163	2	17426148
Pubmed	GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.	GLUD1 GLUD2	2.18e-05	2	163	2	32078638
Pubmed	β-Arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice.	ARRB1 ARRB2	2.18e-05	2	163	2	34344831
Pubmed	Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.	GLUD1 GLUD2	2.18e-05	2	163	2	23595828
Pubmed	ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation.	ARRB1 ARRB2	2.18e-05	2	163	2	36215165
Pubmed	Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1.	ARRB1 ARRB2	2.18e-05	2	163	2	17618287
Pubmed	Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia.	CYFIP2 CYFIP1	2.18e-05	2	163	2	38128786
Pubmed	Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes.	ANXA8L1 ANXA8	2.18e-05	2	163	2	29306076
Interaction	BIRC3 interactions	ATP6V1A POLR1A ATR MYO1D DNAH10 RPS2 DHX37 DUOX2 KRR1 CWC22 CYFIP2 SART1 KARS1 GTF3C1 CTR9 GLUD1 EIF4G1 FEN1 CD40LG PRKDC PEAK1 SNRPA ATP1B3 QARS1 TALDO1 EIF2AK2 TARS1 DYNC1H1 ADGRA3	6.39e-07	1334	160	29	int:BIRC3
Interaction	TOP3B interactions	HEXA MPP3 TRAF7 ARID3A SH3RF1 MYO1D UBE4B POLE FRYL RRM2 BCR LYST RYR1 FZD7 UNC119 NCOR1 SLC7A1 KARS1 TRAPPC12 EFHD1 PI4KA SVIL EIF4G1 IRS2 PRKDC HERC2 SNRPA QARS1 MYRF DYNC1H1	1.48e-06	1470	160	30	int:TOP3B
Interaction	ARRDC4 interactions	MYO1D ARRB1 ARRB2 SLC12A2 PI4KA SVIL HERC2	4.36e-06	83	160	7	int:ARRDC4
Interaction	LRRC31 interactions	DOCK1 KRT78 ATR FRYL PARP14 PI4KA EIF4G1 CNTNAP2 PRKDC HERC2	5.76e-06	205	160	10	int:LRRC31
Interaction	TRPC7 interactions	TRPC7 TRPC3 TRPC6	9.65e-06	6	160	3	int:TRPC7
Interaction	ARRDC3 interactions	TRAF7 BCR FMNL3 SART1 UBE2O ARRB1 ARRB2 SLC12A2 PI4KA UBAC1	1.25e-05	224	160	10	int:ARRDC3
Interaction	FLT1 interactions	FLT1 ATR KRR1 KARS1 PI4KA SVIL PRKDC RAB6A DYNC1H1	1.34e-05	179	160	9	int:FLT1
Interaction	CDC42 interactions	TRAF7 ATP6V1A ATR ELOVL1 FRYL BCR FMNL3 UNC119 SLC7A1 KARS1 CYFIP1 PTPN14 ARRB1 ARRB2 SLC12A2 PI4KA GLUD2 PRKDC PEAK1 HERC2 ZW10 ATP1B3 ARHGEF26 SNX9 EIF2AK2 AMIGO2	1.60e-05	1323	160	26	int:CDC42
Interaction	YWHAG interactions	ATP6V1A SH3RF1 RPS2 FRYL KRR1 RRM2 SHROOM2 BCR CWC22 LYST CYFIP2 UNC119 CYFIP1 PTPN14 ARRB1 ARRB2 CEP95 PI4KA SVIL EIF4G1 IRS2 PRKDC PEAK1 R3HDM1 DYNC1H1	1.73e-05	1248	160	25	int:YWHAG
Interaction	LMBR1L interactions	ATP6V1A POLR1A UBE4B POLE GPS1 SLC7A1 UBE2O KARS1 SLC12A2 PI4KA EIF4G1 FEN1 TRAPPC3 PRKDC ZW10 ATP1B3 QARS1 SNX9 RAB6A TARS1 DYNC1H1	1.98e-05	946	160	21	int:LMBR1L
Interaction	YWHAH interactions	KRT78 SH3RF1 FRYL KRR1 RRM2 BCR CWC22 LYST CYFIP2 UNC119 CYFIP1 PTPN14 ARRB1 ARRB2 SLC12A2 CEP95 PI4KA SVIL EIF4G1 IRS2 PEAK1 R3HDM1 TARS1	2.06e-05	1102	160	23	int:YWHAH
Interaction	SIRT7 interactions	POLR1A ATR MYO1D RPS2 DHX37 POLE FRYL KRR1 SART1 UBE2O KARS1 GTF3C1 EIF4G1 PYGL PRKDC HERC2 SNX9 DYNC1H1	2.67e-05	744	160	18	int:SIRT7
Interaction	KCNA3 interactions	DOCK1 SH3RF1 MYO1D RPS2 CHD9 RYR1 CYFIP1 CEP95 EIF4G1 PYGL IRS2 PRKDC PEAK1 ATP1B3 QARS1 ARHGEF26 SNX9 TARS1 DYNC1H1	6.42e-05	871	160	19	int:KCNA3
Interaction	EFTUD2 interactions	CWF19L2 RPS2 RPP40 GPATCH4 KRR1 PPWD1 SART1 UBE2O KARS1 CYFIP1 ARRB1 ARRB2 TRIR CTR9 GLUD1 EIF4G1 FEN1 PAN2 IRS2 TRAPPC3 PRKDC SNRPA QARS1 EIF2AK2 TARS1 DYNC1H1	7.45e-05	1449	160	26	int:EFTUD2
Interaction	TEC interactions	FLT1 POLR1A CYFIP2 MET CYFIP1 SNX9	8.19e-05	90	160	6	int:TEC
Interaction	TRAPPC13 interactions	NCOR1 COG6 TRAPPC12 PPP4R2 TBC1D14 TRAPPC3	9.26e-05	92	160	6	int:TRAPPC13
Interaction	MAP1B interactions	RPS2 GPS1 BCR KARS1 ARRB1 ARRB2 GLUD1 GLUD2 CNTNAP2 PAN2 PRKDC SNRPA QARS1 DYNC1H1	1.05e-04	539	160	14	int:MAP1B
Interaction	SGO1 interactions	NCOR1 TRAPPC12 CTR9 PRKDC HERC2 ZW10 DNMT3B	1.18e-04	138	160	7	int:SGO1
Interaction	PRNP interactions	ATP6V1A SH3RF1 HCN3 GPS1 ASH1L COL22A1 KRR1 CYFIP2 BLVRA FZD7 NCOR1 UBE2O SLC12A2 NECAB1 TRAPPC12 SVIL GLUD1 FEN1 PAN2 PYGL SNRPA MGA	1.26e-04	1158	160	22	int:PRNP
Interaction	MCM2 interactions	MPP3 RGPD2 ATR TCP11L1 ADA BCR UBE2O KARS1 PPP4R2 GLUD1 GLUD2 EIF4G1 PYGL PRKDC CTNNA2 NME2 QARS1 SNX9 EIF2AK2 TARS1 DYNC1H1	1.34e-04	1081	160	21	int:MCM2
Interaction	EZR interactions	HEXA MPP3 BCR CYFIP2 KARS1 CYFIP1 PTPN14 SLC12A2 EFHD1 PI4KA SVIL PYGL IRS2 PEAK1	1.37e-04	553	160	14	int:EZR
Interaction	MAPK10 interactions	UNC119 ARRB1 ARRB2 GTF3C1 ZW10	1.44e-04	63	160	5	int:MAPK10
GeneFamily	Classical arrestins	ARRB1 ARRB2	2.03e-04	4	106	2	1312
GeneFamily	Transient receptor potential cation channels	TRPC7 TRPC3 TRPC6	5.77e-04	28	106	3	249
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 LYST	1.19e-03	9	106	2	1230
GeneFamily	EF-hand domain containing	DUOX2 CAPN8 DUOX1 NECAB1 EFHD1 MICU2	1.84e-03	219	106	6	863
GeneFamily	Annexins\|Endogenous ligands	ANXA8L1 ANXA8	2.55e-03	13	106	2	404
GeneFamily	Trafficking protein particle complex	TRAPPC12 TRAPPC3	2.96e-03	14	106	2	772
GeneFamily	AT-rich interaction domain containing	ARID3A ARID3C	3.40e-03	15	106	2	418
GeneFamily	C2 domain containing\|Calpains	CAPN6 CAPN8	3.40e-03	15	106	2	975
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MYO1D RYR1 NCOR1 SLC12A2 EIF2AK2	4.27e-03	181	106	5	694
GeneFamily	Dyneins, axonemal	DNAH10 DNAH6	4.37e-03	17	106	2	536
GeneFamily	Aminoacyl tRNA synthetases, Class II	KARS1 TARS1	5.46e-03	19	106	2	132
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP	ARID3A MYO1D DLGAP5 RRM2 FAP PTPN14 PRKDC R3HDM1 PHYHIPL DYNC1H1	6.70e-08	162	161	10	M45037
Coexpression	GRUETZMANN_PANCREATIC_CANCER_UP	MPP3 ANXA8 FAP CYFIP1 GLUD1 PYGL C2 PRKDC R3HDM1 SNRPA ATP1B3 EIF2AK2	2.43e-06	359	161	12	M15193
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PGC CAPN8 MET FREM2 DUOX1 NECAB1 ATP2C2 C2 DCBLD2	5.09e-08	199	162	9	9a65acfe9bf500db72142469cf17bf0973540001
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	PGC CAPN8 MET FREM2 DUOX1 NECAB1 ATP2C2 DCBLD2	5.57e-07	193	162	8	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK1 NIPAL4 MYO1D JAKMIP3 SLC12A2 NECAB1 EFHD1 MYRF	5.79e-07	194	162	8	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	Control-Non-classical_Monocyte-\|Control / Disease condition and Cell class	ADA LYST CYFIP2 UNC119 ARRB1 SVIL ATP1B3 SNX9	6.26e-07	196	162	8	b17ab094cdc7050c2997e24ed474779b5d6f6146
ToppCell	Control-Non-classical_Monocyte\|Control / Disease condition and Cell class	ADA LYST CYFIP2 UNC119 ARRB1 SVIL ATP1B3 SNX9	6.26e-07	196	162	8	404064ccfe2cb73df7a7f88aa65d86b97dcef9d4
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	OAZ2 ADA LYST BLVRA UNC119 ARRB1 ARRB2 ATP1B3	6.76e-07	198	162	8	8de49c62ab533031936db4cee50ff13b259ecc22
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_Tem\|Bac-SEP / Disease, condition lineage and cell class	CWF19L2 FLT1 FMO4 RPS2 DUOX1 BEST4 CD40LG UNC79	6.76e-07	198	162	8	292b26f316f016b50d07689f84772eec46060251
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	OAZ2 ADA LYST BLVRA UNC119 ARRB1 ARRB2 ATP1B3	6.76e-07	198	162	8	60e5bd8dfe27c43ce5f4da19b65270c41577ef4f
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PGC CAPN8 MET FREM2 DUOX1 NECAB1 C2 DCBLD2	7.02e-07	199	162	8	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil\|COVID-19_Severe / Disease, condition lineage and cell class	POLE RRM2 NTNG2 BPI ATP2C2 PYGL IRS2 TALDO1	7.29e-07	200	162	8	cbe667eda1af222467df8bfa157aa22df488f133
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	POLE PARP14 PPWD1 ZNF879 HERC2 AMIGO2 DNMT3B	2.69e-06	167	162	7	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ARID3A ANXA8L1 ANXA8 RYR1 UNC119 CNTNAP2 AJUBA	3.27e-06	172	162	7	58eaadf12366701103a0d1f133462c9495fedc30
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ARID3A ANXA8L1 ANXA8 RYR1 UNC119 CNTNAP2 AJUBA	3.27e-06	172	162	7	4483073469001770015526303772fd54906c5d68
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 MYO1D CAPN8 MET PTPN14 SLC12A2 ADGRA3	4.10e-06	178	162	7	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	COPD-Epithelial-Basal\|World / Disease state, Lineage and Cell class	SH3RF1 TRPC6 ANXA8L1 ANXA8 CAPN8 MET ADGRA3	4.58e-06	181	162	7	6d8a886b4afe729f8a05b9c0f4ea9375de735da4
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	SH3RF1 MYO1D ANXA8L1 PTPN14 PEAK1 ARHGEF26 MYRF	5.28e-06	185	162	7	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC3 CNNM1 FREM2 PTPN14 NECAB1 PHYHIPL DNAH6	5.47e-06	186	162	7	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	MPP3 SH3RF1 MYO1D PTPN14 PEAK1 ARHGEF26 MYRF	5.67e-06	187	162	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 CAPN8 MET FREM2 DUOX1 NECAB1 ATP2C2	6.51e-06	191	162	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	PGC CAPN8 MET FREM2 DUOX1 ATP2C2 DCBLD2	6.51e-06	191	162	7	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	SH3RF1 MYO1D CAPN8 MET FREM2 DUOX1 ATP2C2	6.74e-06	192	162	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	PGC CAPN8 MET FREM2 DUOX1 NECAB1 ATP2C2	6.74e-06	192	162	7	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	PGC CAPN8 MET FREM2 DUOX1 NECAB1 ATP2C2	6.74e-06	192	162	7	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ATR FRYL CTR9 PRKDC MGA EIF2AK2 DYNC1H1	6.97e-06	193	162	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	normal_Lung-Epithelial_cells-AT2\|normal_Lung / Location, Cell class and cell subclass	PGC CAPN8 MET DUOX1 NECAB1 C2 DCBLD2	6.97e-06	193	162	7	80ad1bdc50ecb8a50362f718248441cae20904a6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 PGC CAPN8 MET FREM2 DUOX1 NECAB1	7.21e-06	194	162	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 SH3RF1 MYO1D CAPN8 MET PTPN14 SVIL	7.46e-06	195	162	7	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 SH3RF1 MYO1D CAPN8 MET PTPN14 SVIL	7.46e-06	195	162	7	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASH1L FRYL CYFIP2 RAD51AP2 NCOR1 MGA DYNC1H1	7.46e-06	195	162	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASH1L FRYL CYFIP2 RAD51AP2 NCOR1 MGA DYNC1H1	7.46e-06	195	162	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	OAZ2 ADA LYST BLVRA UNC119 ARRB1 ATP1B3	7.97e-06	197	162	7	46d8c7e9b3aff70bc58894282d0ec9e87d37235f
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	OAZ2 ADA LYST BLVRA UNC119 ARRB1 ATP1B3	7.97e-06	197	162	7	1a82e0e74fc5fd71c490d98e8813d719b0b81aa6
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 SH3RF1 CAPN8 MET FREM2 DUOX1 ATP2C2	8.51e-06	199	162	7	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ANXA8L1 ANXA8 RYR1 CAPN8 MET CNTNAP2 AJUBA	8.51e-06	199	162	7	995d710d7302272e7951a5a5d766d1039089ee2b
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Basal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ANXA8L1 ANXA8 RYR1 CAPN8 MET CNTNAP2 AJUBA	8.51e-06	199	162	7	e9c47f565a0a7737ecff68569d668aeb707ae5a6
ToppCell	Biopsy_Other_PF-Epithelial-KRT5-/KRT17+\|Biopsy_Other_PF / Sample group, Lineage and Cell type	ANXA8L1 CAPN6 ANXA8 MET MMP24 CNTNAP2 MYRF	8.79e-06	200	162	7	077e6b9340686de9d0f11b035a8954e1f6a1b790
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 RPP40 POLE MMP24 PI4KA TARS1	1.47e-05	144	162	6	1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CAPN8 RAD51AP2 PTPN14 BEST4 SVIL AMIGO2	2.15e-05	154	162	6	6c1e7682c43c40b58b371c58deb10b839700ebcc
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FUT10 FLT1 TRPC3 DUOX2 CFAP57 PHYHIPL	2.31e-05	156	162	6	1928c86deb3bcd01db4ae76919a351066aadb39a
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	SH3RF1 ATR CAPN8 MET SLC7A1 MLH3	2.57e-05	159	162	6	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 LAMA2 COL22A1 CAPN8 CNTNAP2 CTNNA2	2.66e-05	160	162	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 LAMA2 COL22A1 CAPN8 CNTNAP2 CTNNA2	2.66e-05	160	162	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SETMAR POLE TRPC6 LAMA2 RAD51AP2 AJUBA	2.76e-05	161	162	6	82ed45f144a07856fe92d37426c5f92e259a03a9
ToppCell	AT1_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	MPP3 ANXA8 FREM3 MMP24 ARHGEF26 MYRF	2.86e-05	162	162	6	ae2ba4f21f6f6c512006fa531d670b88be7c04c9
ToppCell	368C-Epithelial_cells-Epithelial-A_(AT2)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	PGC CAPN8 MET FREM2 DUOX1 ATP2C2	3.06e-05	164	162	6	85f53d184fa70e3eb1af655807f32b17ddbfb304
ToppCell	368C-Epithelial_cells-Epithelial-A_(AT2)\|368C / Donor, Lineage, Cell class and subclass (all cells)	PGC CAPN8 MET FREM2 DUOX1 ATP2C2	3.06e-05	164	162	6	144ba070a1ede71684224cc6d4ead3b7e6a7b4c6
ToppCell	PND01-03-samps-Myeloid\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	HEXA WDFY4 BLVRA UNC119 PYGL TALDO1	3.28e-05	166	162	6	99dc8a186ec12d3563e81fa4618a814740332c73
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 BCR MET PTPN14 C2 DNAH6	4.40e-05	175	162	6	f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69
ToppCell	AT1_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	MPP3 ANXA8 FREM3 MMP24 ARHGEF26 MYRF	4.54e-05	176	162	6	458720776b0151cd55acc352d509599cb62f0ca8
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRPC3 DUOX2 BCR PGC PTPN14 DNAH6	4.54e-05	176	162	6	460cb302c5b3d609c65b924e1d4e8ea057a68485
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC3 TRPC6 LAMA2 BCR RAD51AP2 AJUBA	4.99e-05	179	162	6	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC3 TRPC6 LAMA2 BCR RAD51AP2 AJUBA	4.99e-05	179	162	6	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC134 NPR2 LAMA2 ANXA8 PTPN14 DNAH6	5.31e-05	181	162	6	41969fe4d94ee77b12ecde32170aaf0b13e49644
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC134 NPR2 LAMA2 ANXA8 PTPN14 DNAH6	5.31e-05	181	162	6	3f50e61dc2a52d71a5801584617607e6246adcf2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH3RF1 MYO1D CAPN8 MET ATP2C2 MYRF	5.31e-05	181	162	6	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MET FREM2 DUOX1 NECAB1 ATP2C2 DCBLD2	5.64e-05	183	162	6	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SH3RF1 PGC CAPN8 MET FREM2 NECAB1	5.64e-05	183	162	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	COPD-Epithelial-Basal\|COPD / Disease state, Lineage and Cell class	SH3RF1 TRPC6 ANXA8L1 ANXA8 MET ADGRA3	5.64e-05	183	162	6	0f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SH3RF1 MYO1D PTPN14 PEAK1 ARHGEF26 MYRF	5.81e-05	184	162	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	PGC CAPN8 MET FREM2 DUOX1 ATP2C2	5.81e-05	184	162	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SH3RF1 MYO1D PTPN14 PEAK1 ARHGEF26 MYRF	5.81e-05	184	162	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MPP3 SH3RF1 MYO1D PTPN14 ARHGEF26 MYRF	5.99e-05	185	162	6	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC3 DUOX2 PGC PTPN14 C2 ARID3C	5.99e-05	185	162	6	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	IPF-Myeloid-DC_Langerhans\|Myeloid / Disease state, Lineage and Cell class	MPP3 ACAP1 FLT1 MYO1D TRPC6 CYFIP2	5.99e-05	185	162	6	ced17f69486591c3cbbdc852a3e82c3f3a4a30d7
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC3 DUOX2 PGC PTPN14 C2 ARID3C	5.99e-05	185	162	6	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 CCDC81 ANXA8 ATP2C2 CFAP57 DNAH6	6.17e-05	186	162	6	5ab43a298d23238b34e898d11decf0ad81d1b14e
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	PGC CAPN8 MET FREM2 DUOX1 NECAB1	6.17e-05	186	162	6	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	droplet-Lung-nan-18m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 CCDC81 ANXA8 ATP2C2 CFAP57 DNAH6	6.17e-05	186	162	6	740fd06bcd3b24e6ff2ecf8080f378afc3e95084
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 CCDC81 ANXA8 ATP2C2 CFAP57 DNAH6	6.36e-05	187	162	6	04dba2ed09ee4180830bdf0191921696697ea234
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PGC CAPN8 MET FREM2 DUOX1 NECAB1	6.36e-05	187	162	6	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 CCDC81 ANXA8 ATP2C2 CFAP57 DNAH6	6.36e-05	187	162	6	805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 CCDC81 ANXA8 ATP2C2 CFAP57 DNAH6	6.55e-05	188	162	6	0eca3dc93724e23b71e687fc24fa9f1e89bdef6a
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	SH3RF1 PGC CAPN8 MET FREM2 NECAB1	6.55e-05	188	162	6	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 CCDC81 ANXA8 ATP2C2 CFAP57 DNAH6	6.55e-05	188	162	6	9ce3e1fffce87ad19812ecbf9b7f9935a975d676
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	SH3RF1 CAPN8 MET FREM2 DUOX1 ATP2C2	6.55e-05	188	162	6	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	TRPC3 TRPC6 OAZ2 SHROOM2 EFHD1 ATP1B3	6.74e-05	189	162	6	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 CCDC81 ANXA8 ATP2C2 CFAP57 DNAH6	6.74e-05	189	162	6	fe958fdf9963c2dfe270f67f0da36b3264d0017c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	MPP3 SH3RF1 MYO1D PTPN14 ARHGEF26 MYRF	6.74e-05	189	162	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHD9 OAZ2 PARP14 WDFY4 LYST SNX9	6.74e-05	189	162	6	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	368C-Epithelial_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	PGC CAPN8 MET DUOX1 NECAB1 ATP2C2	6.94e-05	190	162	6	459811e88d3001816c2d89034e0921c24918c17f
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 FSD2 CCDC81 DDO CFAP57 DNAH6	6.94e-05	190	162	6	9ffd18ef358f8e32c610ab6420f479067c8ba44b
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 FSD2 CCDC81 DDO CFAP57 DNAH6	6.94e-05	190	162	6	3ef39d61c98de4e5df946b995847aa65eba6a4b6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CAPN8 MET FREM2 DUOX1 NECAB1 ATP2C2	7.15e-05	191	162	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	control-Non-classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	OAZ2 ADA LYST UNC119 ARRB1 TRIR	7.15e-05	191	162	6	7122957972f177a1d846d965cef53cfe7568ba54
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	RRM2 NTNG2 BPI ATP2C2 PYGL TALDO1	7.35e-05	192	162	6	86d561c30554ff04c21801d4aaf8e3c9efe49af4
ToppCell	COVID-19_Severe-Myeloid_G-immature_Neutrophil\|COVID-19_Severe / Disease group, lineage and cell class	RRM2 NTNG2 BPI ATP2C2 PYGL TALDO1	7.35e-05	192	162	6	303deb68da2e4a75e6ee5a79478182a8bc41c7c5
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MPP3 CAPN6 ANXA8 MMP24 ARHGEF26 MYRF	7.35e-05	192	162	6	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	SH3RF1 MYO1D CAPN8 MET DUOX1 ATP2C2	7.35e-05	192	162	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYO1D SLC12A2 NECAB1 EFHD1 NME2 MYRF	7.57e-05	193	162	6	947200ef6c3a2e35ad7e6b4af29d92384bdf73f5
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PGC CAPN8 MET FREM2 DUOX1 NECAB1	7.57e-05	193	162	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PGC CAPN8 MET FREM2 DUOX1 NECAB1	7.57e-05	193	162	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 MYO1D CAPN8 MET PTPN14 SVIL	7.57e-05	193	162	6	263d185af6ed80e639f864e4966268e0862c61dc
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 POLE RRM2 NTNG2 BPI IRS2	7.57e-05	193	162	6	ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH3RF1 MYO1D MET FREM2 ATP2C2 MYRF	7.57e-05	193	162	6	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ATP6V1A CYFIP2 CNNM1 UBE2O HERC2 RAB6A	7.79e-05	194	162	6	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SH3RF1 PGC CAPN8 FREM2 DUOX1 ARHGEF26	7.79e-05	194	162	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	COVID-19_Severe-Non-classical_Monocyte-\|COVID-19_Severe / Disease condition and Cell class	ADA CYFIP2 UNC119 ARRB1 C2 SNX9	7.79e-05	194	162	6	d70b9039fd2fef3e4be086513b94fb7e9bc1f670
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH10 POLE RRM2 NTNG2 BPI IRS2	7.79e-05	194	162	6	23318a1b55895b5166c6151f488a94a09b4627ff
ToppCell	COVID-19_Severe-Non-classical_Monocyte\|COVID-19_Severe / Disease condition and Cell class	ADA CYFIP2 UNC119 ARRB1 C2 SNX9	7.79e-05	194	162	6	5151546812678ae85cb22224084d27b29e3c4724
ToppCell	Control-Myeloid-CD16_Mono\|Control / Disease, Lineage and Cell Type	OAZ2 LYST BLVRA UNC119 ARRB2 ATP1B3	8.01e-05	195	162	6	a37e75be248ff28f6647e4e690629f82c1fb7370
Drug	ureidoglycine	GLUD1 GLUD2 C2	1.41e-06	4	162	3	CID000439649
Drug	XeC compound	HEXA NPR2 TRPC3 TRPC6 RYR1 KARS1 ATP2C2	2.32e-06	84	162	7	CID000005701
Drug	1-o-phosphonopentofuranose	RRM2 ADA PRTFDC1 PYGL QARS1 TALDO1	4.75e-06	61	162	6	CID000001074
Disease	nicotine dependence (implicated_via_orthology)	TRPC7 TRPC3 TRPC6	3.14e-05	12	157	3	DOID:0050742 (implicated_via_orthology)
Disease	chromosome 15q11.2 deletion syndrome (implicated_via_orthology)	CYFIP2 CYFIP1	8.41e-05	3	157	2	DOID:0060393 (implicated_via_orthology)
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	8.41e-05	3	157	2	DOID:885 (biomarker_via_orthology)
Disease	Benign neoplasm of stomach	ATR POLE MET	9.51e-05	17	157	3	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ATR POLE MET	9.51e-05	17	157	3	C0496905
Disease	Carcinoma in situ of stomach	ATR POLE MET	9.51e-05	17	157	3	C0154060
Disease	phenylketonuria (implicated_via_orthology)	DUOX2 DUOX1	1.68e-04	4	157	2	DOID:9281 (implicated_via_orthology)
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	WDFY4 LYST	1.68e-04	4	157	2	DOID:2935 (implicated_via_orthology)
Disease	Transitional cell carcinoma of bladder	FLT1 BCR	1.68e-04	4	157	2	C0279680
Disease	Stomach Carcinoma	ATR POLE MET	1.83e-04	21	157	3	C0699791
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	4.16e-04	6	157	2	DOID:1825 (biomarker_via_orthology)
Disease	temporal lobe epilepsy (biomarker_via_orthology)	CYFIP1 GLUD1 GLUD2	5.95e-04	31	157	3	DOID:3328 (biomarker_via_orthology)
Disease	Global developmental delay	TRAF7 NTNG2 KARS1 TRAPPC12 CTNNA2	7.44e-04	133	157	5	C0557874
Disease	endometrial cancer (implicated_via_orthology)	ATR POLE	7.71e-04	8	157	2	DOID:1380 (implicated_via_orthology)
Disease	obsolete_red blood cell distribution width	MPP3 NPR2 POLR1A ATR MYO1D HCN3 DUOX2 FREM3 PGC PRTFDC1 CYFIP1 SLC12A2 TBC1D14 IRS2 R3HDM1 ATP1B3 EIF2AK2	8.66e-04	1347	157	17	EFO_0005192
Disease	cholesteryl ester 16:0 measurement	NTNG2 FEN1 MYRF	9.28e-04	36	157	3	EFO_0010341
Disease	vitamin K measurement	COL22A1 CTNNA2	9.88e-04	9	157	2	EFO_0004618
Disease	primary bacterial infectious disease (implicated_via_orthology)	DUOX2 DUOX1	9.88e-04	9	157	2	DOID:0050338 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (O-18:0_20:4) in blood serum	FEN1 MYRF	9.88e-04	9	157	2	OBA_2045127
Disease	Stomach Neoplasms	ATR POLE MET IRS2 CTNNA2 DCBLD2 DNMT3B	1.10e-03	297	157	7	C0038356
Disease	Malignant neoplasm of stomach	ATR POLE MET IRS2 CTNNA2 DCBLD2 DNMT3B	1.17e-03	300	157	7	C0024623
Disease	level of Phosphatidylcholine (O-18:2_16:0) in blood serum	FEN1 MYRF	1.23e-03	10	157	2	OBA_2045132
Disease	late onset Parkinson's disease (is_implicated_in)	GLUD2 EIF4G1	1.50e-03	11	157	2	DOID:0060892 (is_implicated_in)
Disease	peanut allergy measurement, parental genotype effect measurement	RYR1 ATP2C2	1.50e-03	11	157	2	EFO_0005939, EFO_0007017
Disease	cholesteryl ester 20:5 measurement	SVIL FEN1 MYRF	1.67e-03	44	157	3	EFO_0010349
Disease	Adenocarcinoma of large intestine	POLE MET MLH3 PRKDC	1.75e-03	96	157	4	C1319315
Disease	Prostatic Neoplasms	ATR ASH1L MET NCOR1 SLC7A1 SLC12A2 PRKDC MGA EIF2AK2 DNMT3B	1.77e-03	616	157	10	C0033578
Disease	Malignant neoplasm of prostate	ATR ASH1L MET NCOR1 SLC7A1 SLC12A2 PRKDC MGA EIF2AK2 DNMT3B	1.77e-03	616	157	10	C0376358
Disease	Congenital muscular dystrophy	LAMA2 RYR1	1.79e-03	12	157	2	cv:C0699743
Disease	autoimmune thrombocytopenic purpura (is_marker_for)	CD40LG DNMT3B	2.11e-03	13	157	2	DOID:8924 (is_marker_for)
Disease	hypothyroidism (implicated_via_orthology)	DUOX2 DUOX1	2.11e-03	13	157	2	DOID:1459 (implicated_via_orthology)
Disease	actinic keratosis	MMP24 HERC2	2.45e-03	14	157	2	EFO_0002496
Disease	congenital hypothyroidism (implicated_via_orthology)	DUOX2 DUOX1	2.45e-03	14	157	2	DOID:0050328 (implicated_via_orthology)
Disease	diacylglycerol 38:4 measurement	FEN1 MYRF	2.45e-03	14	157	2	EFO_0020066
Disease	Alzheimer's disease (is_marker_for)	ATR GLUD1 CD40LG IRS2 SNRPA DYNC1H1	2.60e-03	257	157	6	DOID:10652 (is_marker_for)
Disease	autoimmune thrombocytopenic purpura (is_implicated_in)	CD40LG DNMT3B	2.82e-03	15	157	2	DOID:8924 (is_implicated_in)
Disease	glycerol-3-phosphate measurement	CNTNAP2 DNMT3B	2.82e-03	15	157	2	EFO_0010488
Disease	cis/trans-18:2 fatty acid measurement, trans fatty acid measurement	FEN1 MYRF	2.82e-03	15	157	2	EFO_0006821, EFO_0006824
Disease	phosphatidate measurement	FEN1 MYRF	2.82e-03	15	157	2	EFO_0020047
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	2.82e-03	15	157	2	DOID:13413 (biomarker_via_orthology)
Disease	diacylglycerol 36:2 measurement	FEN1 MYRF	3.21e-03	16	157	2	EFO_0010355
Disease	autism spectrum disorder (is_implicated_in)	CYFIP1 CNTNAP2	3.21e-03	16	157	2	DOID:0060041 (is_implicated_in)
Disease	systemic lupus erythematosus	ACAP1 ARID3A CHD9 DDO CWC22 WDFY4 LYST FAP NTNG2 COG6 C2	3.77e-03	799	157	11	MONDO_0007915
Disease	lysophosphatidylcholine 22:6 measurement	FZD7 FEN1	4.07e-03	18	157	2	EFO_0010365
Disease	response to clozapine	FZD7 CTNNA2	4.07e-03	18	157	2	GO_0097338
Disease	Malignant neoplasm of endometrium	ATR POLE	4.07e-03	18	157	2	C0007103
Disease	diacylglycerol 36:3 measurement	FEN1 MYRF	4.07e-03	18	157	2	EFO_0020062
Disease	Tourette syndrome, schizophrenia	GGNBP2 DNAH10	4.07e-03	18	157	2	EFO_0004895, MONDO_0005090
Disease	Carcinoma in situ of endometrium	ATR POLE	4.07e-03	18	157	2	C0346191
Disease	pancreatic ductal carcinoma (is_marker_for)	ANXA8 MET DNMT3B	4.24e-03	61	157	3	DOID:3587 (is_marker_for)
Disease	lysophosphatidylcholine measurement	FEN1 MGA MYRF	4.44e-03	62	157	3	EFO_0010224
Disease	cutaneous melanoma, hair color	BCR PTPN14 HERC2	4.44e-03	62	157	3	EFO_0000389, EFO_0003924
Disease	p-tau:beta-amyloid 1-42 ratio measurement	KRT78 DDX49	4.53e-03	19	157	2	EFO_0007709
Disease	esterified cholesterol measurement, high density lipoprotein cholesterol measurement	MPP3 MYRF	4.53e-03	19	157	2	EFO_0004612, EFO_0008589
Disease	emphysema pattern measurement	MYO1D SVIL	4.53e-03	19	157	2	EFO_0005850
Disease	diacylglycerol 38:5 measurement	FEN1 MYRF	4.53e-03	19	157	2	EFO_0020067
Disease	diacylglycerol 38:3 measurement	FEN1 MYRF	4.53e-03	19	157	2	EFO_0020065
Disease	pulmonary non-tuberculous mycobacterial infection	FLT1 BLVRA	4.53e-03	19	157	2	MONDO_0018469
Disease	puberty onset measurement	TRPC7 CYFIP2 HERC2 UNC79	4.54e-03	125	157	4	EFO_0005677
Disease	oral squamous cell carcinoma (is_marker_for)	ADA MET DNMT3B	4.65e-03	63	157	3	DOID:0050866 (is_marker_for)
Disease	body fat percentage	GGNBP2 TRPC7 POLR1A DNAH10 JAKMIP3 ADA NTNG2 UNC79	4.74e-03	488	157	8	EFO_0007800
Disease	Adenocarcinoma of lung (disorder)	FLT1 ATR RRM2 PRKDC EIF2AK2	5.00e-03	206	157	5	C0152013
Disease	diet measurement, body mass index	DOCK1 CNTNAP2	5.02e-03	20	157	2	EFO_0004340, EFO_0008111
Disease	Severe Combined Immunodeficiency	ADA PRKDC	5.02e-03	20	157	2	C0085110
Disease	colorectal cancer	TRPC6 OAZ2 SHROOM2 UBAC1 FEN1 PYGL HERC2 R3HDM1 MYRF	5.19e-03	604	157	9	MONDO_0005575

Protein segments in the cluster

Peptide	Gene	Start	Entry
KLFRRFMSENKIFEG	nan	66	A8MT66
GFMSQEERKKFESLK	BEST4	161	Q8NFU0
TKRDMGFTEEEFKRL	ADA	311	P00813
KTVEAFDADMLKVFR	ASH1L	2506	Q9NR48
EIKSQFEGFVKDIML	CD40LG	86	P29965
AMKVGDKRDISRFLE	DNMT3B	701	Q9UBC3
KDSFMVELVEGARKL	BCR	711	P11274
MERLGEKASRLLEKF	AJUBA	1	Q96IF1
RKEFLDDLFSFMQKR	ARID3C	116	A6NKF2
IFVAEMIEKFGRFTK	ADGRA3	461	Q8IWK6
EDKRKFDIMEFVLRL	ACAP1	181	Q15027
VGRFKLAELMFLDVS	AMIGO2	186	Q86SJ2
VVMEDKEKFSSLGRI	ARHGEF26	346	Q96DR7
GVSSFLIFRKLMLEK	NPR2	471	P20594
FKLFSLLDEDKDGMV	CAPN8	676	A6NHC0
IVFEDFARQRLKGMK	ARRB1	386	P49407
IVFEDFARLRLKGMK	ARRB2	386	P32121
MVEGRVSEFLKKLGF	ATP2C2	1	O75185
ITRMEAEKLFGELFK	R3HDM1	996	Q15032
DFEMKRKFDLVLEEL	RAD51AP2	961	Q09MP3
SDRFVSMKVDFIRLK	PRTFDC1	96	Q9NRG1
GERKAKELNVMFIET	RAB6A	141	P20340
MLIDFFVERKIISFD	OR4M2B	81	A0A0X1KG70
KGFRLVAMKFLRASE	NME2	31	P22392
MKGFSFKEDTLLLIA	C8orf76	301	Q96K31
EKIRGTDEMKFITIL	ANXA8	191	P13928
SFREFLDILVVFMKG	DUOX1	836	Q9NRD9
LGKFINMFAVLDELK	CYFIP1	161	Q7L576
IKSDRKEADIMIFFA	MMP24	211	Q9Y5R2
KEGLLALLEFAEEKM	OAZ2	116	O95190
VDAEILRTMKKVGFI	PAN2	426	Q504Q3
RGEMRDLFEKLKITL	MGA	2436	Q8IWI9
GVDALRKSFEMTVEK	GGNBP2	331	Q9H3C7
RDMKCLVEKLFDFLG	HERC2	2091	O95714
MFKLLRFAEGTLKQT	CFAP57	176	Q96MR6
LIFKESASLMVDRIF	C2	271	P06681
GFMITSKILKVEDRD	FREM2	1676	Q5SZK8
IEVMFAVRKDGFKDH	CWC22	336	Q9HCG8
FREFLDILVVFMKGS	DUOX2	841	Q9NRD8
EVKSRGMKFAEEQLL	GPATCH4	6	Q5T3I0
MFLKQEKLFVELSGE	MLH3	346	Q9UHC1
MLVDFFIERKTISFE	OR4K1	81	Q8NGD4
MLIDFFVERKIISFG	OR4M1	81	Q8NGD0
MLIDFFVERKIISFD	OR4M2	81	Q8NGB6
LLMIKFAEKSLDREG	PEAK1	1701	Q9H792
FRKSLVKMFEDKGLD	CWF19L2	736	Q2TBE0
FEKSLLMGKEFQRRA	GPS1	436	Q13098
FAMKEIIFDLLSVGK	FRYL	421	O94915
MEATEKEQLIKRGVF	FMO4	406	P31512
GEKRLREDISIMIKF	PI4KA	1396	P42356
LMEEIKFKDRAVFVL	JAKMIP3	211	Q5VZ66
FLSKMELEGKLEALR	KRT78	226	Q8N1N4
FSGLKEVRKVVLDTM	KRR1	196	Q13601
LGSAKFIDFLAIEMR	LAMA2	2186	P24043
FIDFLAIEMRKGKVS	LAMA2	2191	P24043
EFVALKKDVDTAFLM	KRT82	221	Q9NSB4
TDKMDLRFGFERLKE	POLE	41	Q07864
LGKFINMFAVLDELK	CYFIP2	161	Q96F07
EKFAFVEVIAMIKGL	CYFIP2	446	Q96F07
FETVAMDRLLRIGKK	HCN3	536	Q9P1Z3
DVVLGFRKMTEAELK	DDO	111	Q99489
LIEFFDRKVLDTIMA	PARP14	271	Q460N5
TILEAMKALKELFEF	IRS2	286	Q9Y4H2
KEMLEALKALSTFFV	COG6	51	Q9Y2V7
TEKLEKLMVRIGVFS	FZD7	461	O75084
DSEDGFIKELFVLRM	ATR	836	Q13535
MFDRASLKLGLDKAV	CHD9	1316	Q3L8U1
KLSRFMFEGREIKLV	DNAH6	1551	Q9C0G6
LIKFMCGEKQFSEER	FEN1	306	P39748
EKIRGTDEMKFITIL	ANXA8L1	191	Q5VT79
IKTFGKMRTDVVDFL	DOCK1	951	Q14185
DLANRFKEFGKEMVK	CTNNA2	171	P26232
KRFGMDFKEIELIGS	EIF2AK2	261	P19525
LLEKFERSESGGKIM	CCDC81	276	Q6ZN84
ITRRFTMELAKKGFI	GLUD1	201	P00367
LQVMVELGKFERKEF	FUT10	26	Q6P4F1
ELAAEDRFMLLFSKV	FMNL3	706	Q8IVF7
KRFLKMSGNFDLSIE	BPI	126	P17213
LSKVGDKMRFDLALA	CTR9	796	Q6PD62
LLMKERFKQFEGLVD	DLGAP5	476	Q15398
TREEMIFKKLFEEGL	CEP95	686	Q96GE4
ELMDTVIFILRKKDG	ELOVL1	121	Q9BW60
KEITGFDLMDLFSVK	COL22A1	241	Q8NFW1
FDLMDLFSVKEILGK	COL22A1	246	Q8NFW1
VELLMEEFAFLKKEV	BLVRA	126	P53004
FIGELFKLKMLTEAI	EIF4G1	901	Q04637
QIRELFMTKKDVDIG	LYST	1721	Q99698
EFSRRLIKDLESMFK	EFHD1	86	Q9BUP0
RFFEREVKMGAKLLQ	DYNC1H1	4411	Q14204
FSIKKIRFLVMDEAD	DDX49	141	Q9Y6V7
RMDFFFTEGARKKKL	C2orf50	141	Q96LR7
FLENMGKEDFIKLEL	CNTNAP2	836	Q9UHC6
KMGERVRIKFGDFDI	DCBLD2	106	Q96PD2
IGFELFKVEMNRKFR	CAPN6	421	Q9Y6Q1
EETRIKFMTDGVLLK	DHX37	341	Q8IY37
KFDNIDKVFKRIMGE	DNAH10	1506	Q8IVF4
FDMFLKLKDIVGSEA	RYR1	4061	P21817
ITRRFTMELAKKGFI	GLUD2	201	P49448
DEMKERILKIVTGFN	PPP4R2	81	Q9NY27
KGEEFARMLTELLFE	FAM114A1	361	Q8IWE2
EDRLKESKVFMRALF	MPP3	221	Q13368
TMLGKELLLFKDRIF	MMP20	306	O60882
FSGRKIMKFIVSIDL	RPP40	136	O75818
FKRVFKVVEEMRGSL	FIBP	141	O43427
MKELELVTKAGFRAL	HEXA	401	P06865
KGLKEFFTLTDLRMR	NTNG2	241	Q96CW9
RKDVGDLMLSFIVKD	FREM3	976	P0C091
VRRLKETKDGFMFLT	MET	216	P08581
MLDEKFTVKVADFGL	MET	1211	P08581
EKAEVIAGRMLKFSV	PHYHIPL	171	Q96FC7
EESLLLFEAMRKGKF	QARS1	381	P47897
FERLEVKKETLLAMF	TARS1	216	P26639
LFREIFSVLDLMKVD	TCP11L1	211	Q9NUJ3
KRKAERDELAGVMIF	SNX9	366	Q9Y5X1
EDILRFMETRFFKLL	POLR1A	1336	O95602
AKRLLFREMEKSFDE	SVIL	696	O95425
VMKRKFSLRAAEFGE	SVIL	1046	O95425
GLTERFELFVMKKEI	KARS1	481	Q15046
RAEEMKSGLKDFKTF	RGPD2	1186	P0DJD1
IKDAVAMADRLGKFL	FSD2	321	A1L4K1
IIRKALMGSFDDKVE	NCOR1	2266	O75376
IFRFVTGKLMRVFDE	PPWD1	306	Q96BP3
TDGNEMIEKREFFKL	MICU2	186	Q8IYU8
RFRTLKKKLEEGMVF	PTPN14	896	Q15678
IRAIFLFEFKMGRKA	SETMAR	351	Q53H47
DKFRMFIGDLDKVVN	SHROOM2	1486	Q13796
EDELELRKGEMFLVF	SH3RF1	461	Q7Z6J0
LDVMLKGLFKVLEDS	CCDC134	66	Q9H6E4
RKEFLDDLFSFMQKR	ARID3A	241	Q99856
QDDRDKFLGRVMFKI	ATP1B3	261	P54709
FSLFKLSDTEMRVKI	CNNM1	591	Q9NRU3
ITAVRKFIEMGFIDE	FAP	601	Q12884
KFIEMGFIDEKRIAI	FAP	606	Q12884
GILKLFEDILTKMDF	TBC1D14	621	Q9P2M4
FKIRDMDSGTVLFEI	UNC119	91	Q13432
EFAKLVGMSVLLAKE	VPS36	341	Q86VN1
ETMKEKGLLGEFLRT	PGC	31	P20142
DAVKDLMLRFLGEKA	TRAPPC12	351	Q8WVT3
FVADRLMLELGFSKV	RRM2	326	P31350
FLFDLKDLVDLMSIG	SLC7A1	401	P30825
FRETADVIAKVAFKM	TRAPPC3	71	O43617
ELFEEVISKMRKAGI	UBE4B	1181	O95155
LSKFRIDFSDIMVLG	SLC12A2	1076	P55011
KTFEDRMDLFSALIK	UBE2O	976	Q9C0C9
FIQRFKEVEKTEGDM	WDFY4	2611	Q6ZS81
EIAFLRSMLGKLSEK	TRAF7	311	Q6Q0C0
VLELEFEGVKEKFTM	ATP6V1A	191	P38606
FREGETMILTLKDKG	SART1	266	O43290
KMKDTGFIVFAVLLL	NIPAL4	191	Q0D2K0
SRLMDEFKIGELFSK	PRKDC	141	P78527
SFKRLMKEALREAVF	ZSWIM3	326	Q96MP5
QEVMKKLIIDGTFDF	ZNF879	101	B4DU55
GIRKFAADAVKLERM	TALDO1	311	P37837
MFVQEEKIFAGKVLR	UBAC1	1	Q9BSL1
SLGRTVKDIFKFMVI	TRPC6	626	Q9Y210
FVDSLEKGKDARALM	WNT8A	146	Q9H1J5
LLQRFKVVKGFMEDE	GTF3C1	406	Q12789
FFLGASLKDEVLKIM	RPS2	96	P15880
AFKFMSLERIKTFEE	FLT1	1216	P17948
IFGMRIDDVAALDKK	PYGL	711	P06737
DLIDIGKFTLMRDFT	ZNF781	131	Q8N8C0
SDIIAKMKGTFVERD	SNRPA	91	P09012
NDGSFLELFKRKMEE	TRIR	61	Q9BQ61
ISLGRTVKDIFKFMV	TRPC3	556	Q13507
SLGRTVKDIFKFMVI	TRPC7	571	Q9HCX4
FENALKEMRFLKGDT	ZW10	371	O43264
LKEFREVLSKMFDIE	UNC79	641	Q9P2D8
QEEDFTKKMLGRIFE	NLRP13	646	Q86W25
EFRVVADAMKVIGFK	MYO1D	246	O94832
KERIFMENVGAVKEL	MYRF	671	Q9Y2G1
KGMSIFLDILRRADK	NECAB1	26	Q8N987